Regulatory FDA moves toward easing restrictions on certain peptides BioPharma DiveThe agency s decision to hold an advisory committee meeting on the topic comes after HHS Secretary Robert F.RegulatoryRead full story pharminent April 16, 2026 (Last updated: April 17, 2026) BioPharma Dive The agency s decision to hold an advisory committee meeting on the topic comes after HHS Secretary Robert F. RegulatoryRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Lilly’s new obesity pill passes heart safety test in diabetesNext: Erica Schwartz, ex-deputy surgeon general, picked to be next CDC director Related Stories Regulatory FDA approves MSD’s Keytruda combinations for MIBC pharminent July 13, 2026 Regulatory FDA freezes CRL trove as ‘radical transparency’ push hits speedbump pharminent July 9, 2026 Regulatory UK first in Europe to clear Boehringer’s IPF drug Jascayd pharminent July 9, 2026
